Chennai-based Global Pharma Healthcare, which has been under the scanner of the US FDA for potential bacterial contamination of its eye-drops, has been asked to stop production of its ophthalmic range of products at its site.
A joint team of officials from the Central Drugs Standard Control Organisation (CDSCO) and State Drug Controller inspected the site on Friday.
A joint team of officials from the Central Drugs Standard Control Organisation (CDSCO) and State Drug Controller inspected the site on Friday.
In the joint investigation report (Business Standard has a copy of the report) the drug inspector CDSCO South Zone C Manivillavan and Deepa Joseph, senior drugs inspector, Kancheepuram zone, Director of Drugs Control, Tamil Nadu have noted that the